Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease
Condition(s):Peripheral Arterial DiseaseLast Updated:March 12, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Peripheral Arterial DiseaseLast Updated:March 12, 2020Unknown status
Condition(s):Peripheral Arterial DiseaseLast Updated:March 31, 2022Unknown status
Condition(s):Peripheral Arterial Disease; Sedentary Behavior; Sedentary Time; Peripheral Arterial Occlusive DiseaseLast Updated:July 27, 2023Not yet recruiting
Condition(s):Peripheral Arterial Disease (PAD); Moderate Risk for Cardiovascular Disease (CVD)Last Updated:March 20, 2012Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:November 1, 2023Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:April 30, 2013Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:May 2, 2017Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:September 20, 2013Completed
Condition(s):Peripheral Arterial Disease; Quality of Life; Quality of CareLast Updated:June 15, 2023Active, not recruiting
Condition(s):Peripheral Vascular DiseasesLast Updated:September 9, 2014Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.